{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1360004236759920512.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1182/blood-2014-04-570572"}},{"identifier":{"@type":"URI","@value":"http://ashpublications.org/blood/article-pdf/124/19/2996/1381193/2996.pdf"}},{"identifier":{"@type":"PMID","@value":"25377559"}}],"resourceType":"学術雑誌論文(journal article)","dc:title":[{"@value":"JAK2V617F+ myeloproliferative neoplasm clones evoke paracrine DNA damage to adjacent normal cells through secretion of lipocalin-2"}],"description":[{"type":"abstract","notation":[{"@value":"<jats:title>Key Points</jats:title>\n               <jats:p>JAK2V617F+ MPN clones induce paracrine DNA damage into coexisting normal clones through secretion of lipocalin-2. Lipocalin-2 suppresses normal hematopoiesis via p53 pathway activation and gives relative growth advantage to MPN clones.</jats:p>"}]}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1420282801189814784","@type":"Researcher","personIdentifier":[{"@type":"KAKEN_RESEARCHERS","@value":"70706960"},{"@type":"NRID","@value":"1000070706960"},{"@type":"NRID","@value":"9000290820619"},{"@type":"NRID","@value":"9000018840344"},{"@type":"NRID","@value":"9000361681541"},{"@type":"NRID","@value":"9000017177985"},{"@type":"NRID","@value":"9000282421957"},{"@type":"RESEARCHMAP","@value":"https://researchmap.jp/yukikagoya"}],"foaf:name":[{"@value":"Yuki Kagoya"}],"jpcoar:affiliationName":[{"@value":"Department of Hematology and Oncology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan; and"}]},{"@id":"https://cir.nii.ac.jp/crid/1420003854341236480","@type":"Researcher","personIdentifier":[{"@type":"KAKEN_RESEARCHERS","@value":"80609016"},{"@type":"NRID","@value":"1000080609016"},{"@type":"NRID","@value":"9000002132252"},{"@type":"NRID","@value":"9000001853205"},{"@type":"NRID","@value":"9000263062237"},{"@type":"NRID","@value":"9000412524555"},{"@type":"NRID","@value":"9000336384319"},{"@type":"NRID","@value":"9000283537855"},{"@type":"NRID","@value":"9000019129944"},{"@type":"NRID","@value":"9000398799071"},{"@type":"NRID","@value":"9000248217286"},{"@type":"NRID","@value":"9000261674919"},{"@type":"NRID","@value":"9000301744792"},{"@type":"NRID","@value":"9000409505537"},{"@type":"RESEARCHMAP","@value":"https://researchmap.jp/akihideyoshimi"}],"foaf:name":[{"@value":"Akihide Yoshimi"}],"jpcoar:affiliationName":[{"@value":"Department of Hematology and Oncology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan; and"}]},{"@id":"https://cir.nii.ac.jp/crid/1380004236759920771","@type":"Researcher","foaf:name":[{"@value":"Takako Tsuruta-Kishino"}],"jpcoar:affiliationName":[{"@value":"Department of Hematology and Oncology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan; and"}]},{"@id":"https://cir.nii.ac.jp/crid/1380004236759920389","@type":"Researcher","foaf:name":[{"@value":"Shunya Arai"}],"jpcoar:affiliationName":[{"@value":"Department of Hematology and Oncology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan; and"}]},{"@id":"https://cir.nii.ac.jp/crid/1380004236759920904","@type":"Researcher","foaf:name":[{"@value":"Takashi Satoh"}],"jpcoar:affiliationName":[{"@value":"Laboratory of Host Defense, World Premier International Research Center Initiative, Immunology Frontier Research Center, and"},{"@value":"Department of Host Defense, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan"}]},{"@id":"https://cir.nii.ac.jp/crid/1380004236759920387","@type":"Researcher","foaf:name":[{"@value":"Shizuo Akira"}],"jpcoar:affiliationName":[{"@value":"Laboratory of Host Defense, World Premier International Research Center Initiative, Immunology Frontier Research Center, and"},{"@value":"Department of Host Defense, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan"}]},{"@id":"https://cir.nii.ac.jp/crid/1420845751154956416","@type":"Researcher","personIdentifier":[{"@type":"KAKEN_RESEARCHERS","@value":"80312320"},{"@type":"NRID","@value":"1000080312320"},{"@type":"NRID","@value":"9000021702267"},{"@type":"NRID","@value":"9000020739647"}],"foaf:name":[{"@value":"Mineo Kurokawa"}],"jpcoar:affiliationName":[{"@value":"Department of Hematology and Oncology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan; and"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"00064971"},{"@type":"EISSN","@value":"15280020"}],"prism:publicationName":[{"@value":"Blood"}],"dc:publisher":[{"@value":"American Society of Hematology"}],"prism:publicationDate":"2014-11-06","prism:volume":"124","prism:number":"19","prism:startingPage":"2996","prism:endingPage":"3006"},"reviewed":"false","dcterms:accessRights":"http://purl.org/coar/access_right/c_abf2","url":[{"@id":"http://ashpublications.org/blood/article-pdf/124/19/2996/1381193/2996.pdf"}],"createdAt":"2014-09-13","modifiedAt":"2019-11-18","foaf:topic":[{"@id":"https://cir.nii.ac.jp/all?q=Mice,%20Knockout","dc:title":"Mice, Knockout"},{"@id":"https://cir.nii.ac.jp/all?q=Oncogene%20Proteins","dc:title":"Oncogene Proteins"},{"@id":"https://cir.nii.ac.jp/all?q=Iron%20Overload","dc:title":"Iron Overload"},{"@id":"https://cir.nii.ac.jp/all?q=Myeloproliferative%20Disorders","dc:title":"Myeloproliferative Disorders"},{"@id":"https://cir.nii.ac.jp/all?q=Janus%20Kinase%202","dc:title":"Janus Kinase 2"},{"@id":"https://cir.nii.ac.jp/all?q=Lipocalins","dc:title":"Lipocalins"},{"@id":"https://cir.nii.ac.jp/all?q=Hematopoiesis","dc:title":"Hematopoiesis"},{"@id":"https://cir.nii.ac.jp/all?q=Mice,%20Inbred%20C57BL","dc:title":"Mice, Inbred C57BL"},{"@id":"https://cir.nii.ac.jp/all?q=Oxidative%20Stress","dc:title":"Oxidative Stress"},{"@id":"https://cir.nii.ac.jp/all?q=Cell%20Transformation,%20Neoplastic","dc:title":"Cell Transformation, Neoplastic"},{"@id":"https://cir.nii.ac.jp/all?q=Pyrimidines","dc:title":"Pyrimidines"},{"@id":"https://cir.nii.ac.jp/all?q=Lipocalin-2","dc:title":"Lipocalin-2"},{"@id":"https://cir.nii.ac.jp/all?q=Nitriles","dc:title":"Nitriles"},{"@id":"https://cir.nii.ac.jp/all?q=Paracrine%20Communication","dc:title":"Paracrine Communication"},{"@id":"https://cir.nii.ac.jp/all?q=Animals","dc:title":"Animals"},{"@id":"https://cir.nii.ac.jp/all?q=Pyrazoles","dc:title":"Pyrazoles"},{"@id":"https://cir.nii.ac.jp/all?q=Female","dc:title":"Female"},{"@id":"https://cir.nii.ac.jp/all?q=Tumor%20Suppressor%20Protein%20p53","dc:title":"Tumor Suppressor Protein p53"},{"@id":"https://cir.nii.ac.jp/all?q=Acute-Phase%20Proteins","dc:title":"Acute-Phase Proteins"},{"@id":"https://cir.nii.ac.jp/all?q=DNA%20Damage","dc:title":"DNA Damage"}],"project":[{"@id":"https://cir.nii.ac.jp/crid/1040000782194376960","@type":"Project","projectIdentifier":[{"@type":"KAKEN","@value":"24249055"},{"@type":"JGN","@value":"JP24249055"},{"@type":"URI","@value":"https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-24249055/"}],"notation":[{"@language":"ja","@value":"統合的病態パスウェイ解析に基づく白血病の発症機構と治療基盤の確立"},{"@language":"en","@value":"Establishment of a platform for elucidation of molecular pathogenesis of leukemia and antileukemia therapy based on  integrated pathway analysis"}]},{"@id":"https://cir.nii.ac.jp/crid/1040000782277363456","@type":"Project","projectIdentifier":[{"@type":"KAKEN","@value":"25893047"},{"@type":"JGN","@value":"JP25893047"},{"@type":"URI","@value":"https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-25893047/"}],"notation":[{"@language":"ja","@value":"骨髄増殖性腫瘍の急性骨髄性白血病への進展機構の解明と新規治療法確立への応用"},{"@language":"en","@value":"Elucidation of the mechanism of transformation of myeloproliferative neoplasm into acute myelogenous leukemia for novel therapeutic strategy for the disease."}]},{"@id":"https://cir.nii.ac.jp/crid/1040000782318507392","@type":"Project","projectIdentifier":[{"@type":"KAKEN","@value":"26860474"},{"@type":"JGN","@value":"JP26860474"},{"@type":"URI","@value":"https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-26860474/"}],"notation":[{"@language":"ja","@value":"iPS細胞を用いた顆粒球輸血療法確立を目指した科学的基盤形成"},{"@language":"en","@value":"Establishment of scientific basis for iPS cell-rerived granulocyte transfusion strategy"}]}],"relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1360004233459094656","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"A germline HLTF mutation in familial MDS induces DNA damage accumulation through impaired PCNA polyubiquitination"}]},{"@id":"https://cir.nii.ac.jp/crid/1360011144572732544","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Changes in parameters of oxidative stress and free iron biomarkers during treatment with deferasirox in iron-overloaded patients with myelodysplastic syndromes"}]},{"@id":"https://cir.nii.ac.jp/crid/1360011145113702016","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"JAK2 stimulates homologous recombination and genetic instability: potential implication in the heterogeneity of myeloproliferative disorders"}]},{"@id":"https://cir.nii.ac.jp/crid/1360011146297017344","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron"}]},{"@id":"https://cir.nii.ac.jp/crid/1360283693782898688","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Positive feedback between NF-κB and TNF-α promotes leukemia-initiating cell capacity"}]},{"@id":"https://cir.nii.ac.jp/crid/1360292620321238272","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Genetic Analysis of Transforming Events That Convert Chronic Myeloproliferative Neoplasms to Leukemias"}]},{"@id":"https://cir.nii.ac.jp/crid/1360292621300476928","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Essential Thrombocythemia Beyond the First Decade: Life Expectancy, Long-term Complication Rates, and Prognostic Factors"}]},{"@id":"https://cir.nii.ac.jp/crid/1360572092664557696","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Clonal expansion in non-cancer tissues"}]},{"@id":"https://cir.nii.ac.jp/crid/1360574094567486080","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Expression of a homodimeric type I cytokine receptor is required for JAK2V617F-mediated transformation"}]},{"@id":"https://cir.nii.ac.jp/crid/1360574095614300288","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Two routes to leukemic transformation after a JAK2 mutation–positive myeloproliferative neoplasm"}]},{"@id":"https://cir.nii.ac.jp/crid/1360855568884538240","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Phenotypic Polarization of Activated Astrocytes: The Critical Role of Lipocalin-2 in the Classical Inflammatory Activation of Astrocytes"}]},{"@id":"https://cir.nii.ac.jp/crid/1360855569238328448","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Mutations of the TP53 gene in acute myeloid leukemia are strongly associated with a complex aberrant karyotype"}]},{"@id":"https://cir.nii.ac.jp/crid/1360855569349822592","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Iron, Free Radicals, and Oxidative Injury"}]},{"@id":"https://cir.nii.ac.jp/crid/1360855569545242240","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Independently acquired biallelic JAK2 mutations are present in a minority of patients with essential thrombocythemia"}]},{"@id":"https://cir.nii.ac.jp/crid/1360855570619004032","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Somatic Mutations of Calreticulin in Myeloproliferative Neoplasms"}]},{"@id":"https://cir.nii.ac.jp/crid/1361137044852956160","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"JAK2V617F negatively regulates p53 stabilization by enhancing MDM2 via La expression in myeloproliferative neoplasms"}]},{"@id":"https://cir.nii.ac.jp/crid/1361137045727172480","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"JAK2V617F expression in murine hematopoietic cells leads to MPD mimicking human PV with secondary myelofibrosis"}]},{"@id":"https://cir.nii.ac.jp/crid/1361137046218793216","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"p53 Lesions in Leukemic Transformation"}]},{"@id":"https://cir.nii.ac.jp/crid/1361137046293913216","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Leukemic transformation in myelofibrosis with myeloid metaplasia: a single-institution experience with 91 cases"}]},{"@id":"https://cir.nii.ac.jp/crid/1361418518396476416","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"The neutrophil gelatinase-associated lipocalin (NGAL), a NF-κB-regulated gene, is a survival factor for thyroid neoplastic cells"}]},{"@id":"https://cir.nii.ac.jp/crid/1361418519257510912","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Bcr-Abl-mediated suppression of normal hematopoiesis in leukemia"}]},{"@id":"https://cir.nii.ac.jp/crid/1361418521446018304","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Lipocalin 2 is required for BCR-ABL-induced tumorigenesis"}]},{"@id":"https://cir.nii.ac.jp/crid/1361418521449975936","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Analyzing real-time PCR data by the comparative CT method"}]},{"@id":"https://cir.nii.ac.jp/crid/1361699994840037120","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Characterization of Murine JAK2V617F-Positive Myeloproliferative Disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1361699995117671424","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Development of ET, primary myelofibrosis and PV in mice expressing JAK2 V617F"}]},{"@id":"https://cir.nii.ac.jp/crid/1361699995543307776","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"DNMT3A mutational analysis in primary myelofibrosis, chronic myelomonocytic leukemia and advanced phases of myeloproliferative neoplasms"}]},{"@id":"https://cir.nii.ac.jp/crid/1361981468495973504","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Hematopoietic Stem Cell Quiescence Promotes Error-Prone DNA Repair and Mutagenesis"}]},{"@id":"https://cir.nii.ac.jp/crid/1361981469117574016","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"A Cell-Surface Receptor for Lipocalin 24p3 Selectively Mediates Apoptosis and Iron Uptake"}]},{"@id":"https://cir.nii.ac.jp/crid/1361981469212047616","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Conditional expression of heterozygous or homozygous Jak2V617F from its endogenous promoter induces a polycythemia vera–like disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1361981469239700992","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"The Role of JAK Pathway Dysregulation in the Pathogenesis and Treatment of Acute Myeloid Leukemia"}]},{"@id":"https://cir.nii.ac.jp/crid/1361981471066024448","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Acute Myeloid Leukemia and Myelodysplastic Syndromes Following Essential Thrombocythemia Treated With Hydroxyurea: High Proportion of Cases With 17p Deletion"}]},{"@id":"https://cir.nii.ac.jp/crid/1362262943962135680","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Lipocalin-2 Deficiency Attenuates Insulin Resistance Associated With Aging and Obesity"}]},{"@id":"https://cir.nii.ac.jp/crid/1362262945312167424","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Clonal analysis of TET2 and JAK2 mutations suggests that TET2 can be a late event in the progression of myeloproliferative neoplasms"}]},{"@id":"https://cir.nii.ac.jp/crid/1362544420255911168","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"IDH1 and IDH2 mutation analysis in chronic- and blast-phase myeloproliferative neoplasms"}]},{"@id":"https://cir.nii.ac.jp/crid/1362544420354735232","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Physiological Jak2V617F Expression Causes a Lethal Myeloproliferative Neoplasm with Differential Effects on Hematopoietic Stem and Progenitor Cells"}]},{"@id":"https://cir.nii.ac.jp/crid/1362544420418350336","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Leukemic blasts in transformed JAK2-V617F–positive myeloproliferative disorders are frequently negative for the JAK2-V617F mutation."}]},{"@id":"https://cir.nii.ac.jp/crid/1362825893862977024","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Expression of Jak2V617F causes a polycythemia vera–like disease with associated myelofibrosis in a murine bone marrow transplant model"}]},{"@id":"https://cir.nii.ac.jp/crid/1362825895318539008","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"AML1/RUNX1 point mutation possibly promotes leukemic transformation in myeloproliferative neoplasms"}]},{"@id":"https://cir.nii.ac.jp/crid/1362825895916727168","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"A Gain-of-Function Mutation of\n                    <i>JAK2</i>\n                    in Myeloproliferative Disorders"}]},{"@id":"https://cir.nii.ac.jp/crid/1362825896126672640","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disorders"}]},{"@id":"https://cir.nii.ac.jp/crid/1362825896204531840","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Analyses of TET2 mutations in post-myeloproliferative neoplasm acute myeloid leukemias"}]},{"@id":"https://cir.nii.ac.jp/crid/1363107368600802560","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"JAK2 V617F impairs hematopoietic stem cell function in a conditional knock-in mouse model of JAK2 V617F–positive essential thrombocythemia"}]},{"@id":"https://cir.nii.ac.jp/crid/1363107368780653696","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera"}]},{"@id":"https://cir.nii.ac.jp/crid/1363107368791726848","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"JAK/STAT signaling in hematological malignancies"}]},{"@id":"https://cir.nii.ac.jp/crid/1363107369954881792","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders"}]},{"@id":"https://cir.nii.ac.jp/crid/1363107371129124992","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Genome integrity of myeloproliferative neoplasms in chronic phase and during disease progression"}]},{"@id":"https://cir.nii.ac.jp/crid/1363388844631396864","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Transgenic expression of JAK2V617F causes myeloproliferative disorders in mice"}]},{"@id":"https://cir.nii.ac.jp/crid/1363388845125869440","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Mutation of the AML1/RUNX1 gene in a transient myeloproliferative disorder patient with Down syndrome"}]},{"@id":"https://cir.nii.ac.jp/crid/1363388846327383936","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Myeloproliferative neoplasm induced by constitutive expression of JAK2V617F in knock-in mice"}]},{"@id":"https://cir.nii.ac.jp/crid/1363670319962255744","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis"}]},{"@id":"https://cir.nii.ac.jp/crid/1363670320163110528","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Nitric oxide generation from hydroxyurea: significance and implications for leukemogenesis in the management of myeloproliferative disorders"}]},{"@id":"https://cir.nii.ac.jp/crid/1363951793843740928","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Clonal evolution and clinical correlates of somatic mutations in myeloproliferative neoplasms"}]},{"@id":"https://cir.nii.ac.jp/crid/1363951793886667776","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Mutation of JAK2 in the myeloproliferative disorders: timing, clonality studies, cytogenetic associations, and role in leukemic transformation"}]},{"@id":"https://cir.nii.ac.jp/crid/1363951794631602304","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Transcription and signalling pathways involved in BCR–ABL‐mediated misregulation of 24p3 and 24p3R"}]},{"@id":"https://cir.nii.ac.jp/crid/1370004236759920516","@type":"Product","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Molecular mechanisms of tumor progression in chronic myeloproliferative disorders."}]},{"@id":"https://cir.nii.ac.jp/crid/1370004236759920640","@type":"Product","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Enhanced proliferative potential in culture of cells from p53-deficient mice."}]},{"@id":"https://cir.nii.ac.jp/crid/1370004236759920642","@type":"Product","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Lnk controls mouse hematopoietic stem cell self-renewal and quiescence through direct interactions with JAK2."}]},{"@id":"https://cir.nii.ac.jp/crid/1370004236759920772","@type":"Product","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"The very long-term evolution of polycythemia vera: an analysis of 318 patients initially treated by phlebotomy or 32P between 1969 and 1981."}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1182/blood-2014-04-570572"},{"@type":"KAKEN","@value":"PRODUCT-14505502"},{"@type":"KAKEN","@value":"PRODUCT-15185745"},{"@type":"KAKEN","@value":"PRODUCT-15303629"},{"@type":"OPENAIRE","@value":"doi_dedup___::50f2786ab9593bb1ae1918631e2d1692"},{"@type":"CROSSREF","@value":"10.1038/s41375-019-0385-0_references_DOI_NsPSMfesreJewixtkIzT60cSpoQ"},{"@type":"CROSSREF","@value":"10.1038/s41568-021-00335-3_references_DOI_NsPSMfesreJewixtkIzT60cSpoQ"}]}